FDA Approves Lilly's Ultra-Rapid-Acting Insulin, Lyumjev FDA Approves Lilly's Ultra-Rapid-Acting Insulin, Lyumjev
The novel rapid-acting formulation of insulin lispro is approved for adults with type 1 and type 2 diabetes.FDA Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 18, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

FDA Approves Lyumjev (insulin lispro-aabc injection) for Type 1 and Type 2 Diabetes
INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's (NYSE: LLY) new rapid-acting insulin indicated to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 15, 2020 Category: Drugs & Pharmacology Source Type: news

First Approval for Fast-Acting Lispro for Diabetes; EU OKs Oral Semaglutide First Approval for Fast-Acting Lispro for Diabetes; EU OKs Oral Semaglutide
EMA panel recommends approval of oral GLP-1 agonist semaglutide for type 2 diabetes. It has also given the thumbs up to a mealtime, or fast-acting form, of insulin lispro for adults with diabetes.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 31, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Insulin donation, along with $2 million in grants to relief agencies, extends program launched in 2018 INDIANAPOLIS, Jan. 28, 2020 -- (Healthcare Sales & Marketing Network) -- Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least ... Biopharmaceuticals, Drug Delivery, Endocrinology Eli Lilly, KwikPen, insulin, Humalog, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 28, 2020 Category: Pharmaceuticals Source Type: news

Eli Lilly to offer half-priced versions of two more insulin products
Eli Lilly and Co said on Tuesday it plans to sell two versions of insulin products at half their current U.S. list prices, eight months after it started selling a half-priced version of its widely-used Humalog injection. (Source: Reuters: Health)
Source: Reuters: Health - January 14, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Collaboration Makes the Diabetes World Go & #039;Round
In the world of diabetes technologies, collaboration is the name of the game. Medtronic and Novo Nordisk are working together to integrate insulin dosing data from future Novo Nordisk smart insulin pens into continuous glucose monitoring (CGM) devices from Medtronic, such as the Guardian Connect system shown above. At the same time, Abbott and Sanofi will be working on tools that combine Abbott's FreeStyle Libre technology with Sanofi's insulin dosing information. "We see incredible power in combining a variety of data points to drive insights that help people living with diabetes make more informed decisions around m...
Source: MDDI - September 17, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Half-Price Version of Humalog Insulin Available
The company's generic version of its Humalog U-100 is being sold under the chemical name insulin lispro, (Source: WebMD Health)
Source: WebMD Health - May 23, 2019 Category: Consumer Health News Source Type: news

Half-Price Version of Humalog Insulin Now Available
Title: Half-Price Version of Humalog Insulin Now AvailableCategory: Health NewsCreated: 5/22/2019 12:00:00 AMLast Editorial Review: 5/23/2019 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - May 23, 2019 Category: Endocrinology Source Type: news

Eli Lilly's lower-priced insulin goes on sale amid drug price debate
A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. (Source: CNN.com - Health)
Source: CNN.com - Health - May 22, 2019 Category: Consumer Health News Source Type: news

Half-Price Version of Humalog Insulin Now Available
WEDNESDAY, May 22, 2019 -- A half-price version of Humalog insulin is now available in the United States, Eli Lilly said Wednesday. The company's generic version of its Humalog U-100 is being sold under the chemical name insulin lispro, the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2019 Category: Pharmaceuticals Source Type: news

Eli Lilly's half-price insulin goes on sale, but critics say it's still too costly
Eli Lilly's lower-cost version of its Humalog insulin still costs much more than insulin sold outside the U.S. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 22, 2019 Category: Consumer Health News Source Type: news

Lilly selling half-price version of popular Humalog insulin
A half-price version of Eli Lilly's popular Humalog insulin is now available under the name Insulin Lispro, after the drugmaker promised a more affordable option amid soaring insulin prices. (Source: ABC News: Health)
Source: ABC News: Health - May 22, 2019 Category: Consumer Health News Tags: Health Source Type: news

Medical News Today: What's the difference between Humalog and NovoLog?
Humalog and NovoLog are types of medication that can help control blood sugar levels in people with diabetes. Learn about the differences between them here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 9, 2019 Category: Consumer Health News Tags: Diabetes Source Type: news

Generic Humalog; 23andMe T2D Test; Menopause Ads Blocked
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 15, 2019 Category: Cardiology Source Type: news

How Much Difference Will Eli Lilly's Half-Price Insulin Make? How Much Difference Will Eli Lilly's Half-Price Insulin Make?
Lilly is rolling out a half-priced version of its insulin Humalog that will be sold as a generic.Kaiser Health News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 13, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Eli Lilly Offers Lower-Priced Version of its Lispro Insulin Eli Lilly Offers Lower-Priced Version of its Lispro Insulin
The new'authorized generic'is the same product as Humalog, offered through a Lilly subsidiary at about half the list price to patients paying out of pocket.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 5, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Drug Maker To Sell Cheaper Version of Insulin
A cheaper version of Eli Lilly's most popular insulin drug, Humalog, is being introduced by the drug maker. (Source: WebMD Health)
Source: WebMD Health - March 4, 2019 Category: Consumer Health News Source Type: news

Eli Lilly To Sell Generic Version Of Insulin At Half Price
(CNN) — Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. At 50% the price of Humalog, the generic insulin lispro will carry a list price of $137.35 per vial, the company said, or $265.20 for a pack of five pens. Brand-name Humalog will remain on the market. The move comes amid growing concerns about the soaring prices of drugs — insulin in particular — which have led many people with diabetes to cut back on their insulin in order to save on costs, in some cases leading to harmful or e...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 4, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News CNN Diabetes insulin Source Type: news

Eli Lilly to Sell Cheaper Version of Insulin Drug
MONDAY, March 4, 2019 -- A cheaper version of Eli Lilly's most popular insulin drug, Humalog, is being introduced by the drug maker. The " authorized generic " of Humalog 100 will sell for $137.35 per vial, 50 percent lower than the list price for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 4, 2019 Category: Pharmaceuticals Source Type: news

Lilly to sell cheaper version of top-selling insulin Humalog
Eli Lilly is offering a half-price version of its top-selling insulin Humalog (Source: ABC News: Health)
Source: ABC News: Health - March 4, 2019 Category: Consumer Health News Tags: Health Source Type: news

Amid uproar over high drug prices, Eli Lilly introduces generic insulin at half price of brand-name Humalog
Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. (Source: CNN.com - Health)
Source: CNN.com - Health - March 4, 2019 Category: Consumer Health News Source Type: news

Eli Lilly seeks to quell drug price anger with cheaper insulin
Drugmaker Eli Lilly and Co announced plans on Monday to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in the United States. (Source: Reuters: Health)
Source: Reuters: Health - March 4, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Lilly to offer authorized generic of blockbuster insulin
Eli Lilly plans to sell an authorized generic version of its blockbuster insulin, Humalog, for half the cost (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - March 4, 2019 Category: Pharmaceuticals Source Type: news

Eli Lilly Will Sell Half-Price Version of Humalog, Its Popular Insulin
The drugmaker ’ s decision to sell a generic version comes with the industry under pressure to do something about rising list prices. (Source: NYT Health)
Source: NYT Health - March 4, 2019 Category: Consumer Health News Authors: KATIE THOMAS Tags: your-feed-science Eli Lilly and Company Insulin Humalog Drugs (Pharmaceuticals) Generic Brands and Products Diabetes Health Insurance and Managed Care Source Type: news

Morning Break: Vaccine Battles Rage; Half-Price Humalog; Cannabinoid Factories
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 4, 2019 Category: Endocrinology Source Type: news

Lilly to Introduce Lower-Priced Insulin
Authorized generic version of Humalog will be available in U.S. pharmacies at 50 percent lower list price INDIANAPOLIS, March 4, 2019 -- (Healthcare Sales & Marketing Network) -- Reinforcing our commitment to lower out-of-pocket costs for people who ne... Biopharmaceuticals, Endocrinology, Product Launch Eli Lilly, Humalog, diabetes, insulin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 4, 2019 Category: Pharmaceuticals Source Type: news

Health Highlights: March 4, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Eli Lilly to Sell Cheaper Version of Insulin Drug A cheaper version of Eli Lilly's most popular insulin drug, Humalog, is being introduced by the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 4, 2019 Category: General Medicine Source Type: news

Admelog (Insulin Lispro Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 27, 2018 Category: Drugs & Pharmacology Source Type: news

Humalog 75-25 (75-25 Insulin Lispro Suspension and 25 Insulin Lispro Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 9, 2018 Category: Drugs & Pharmacology Source Type: news

Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Eli Lilly and Co said on Tuesday its experimental diabetes treatment was shown to be as effective as the drugmaker's Humalog medicine in two late-stage studies. (Source: Reuters: Health)
Source: Reuters: Health - October 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Lilly plans Elanco IPO, posts quarterly profit above estimates
Eli Lilly and Co said on Tuesday it would take its Elanco animal health business public and posted a better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Eli Lilly to take animal health unit public, profit beats estimates
Eli Lilly and Co announced on Tuesday it would take its Elanco animal health business public and posted better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Eli Lilly to spin off animal health unit, quarterly profit beats estimates
Eli Lilly and Co announced on Tuesday it would spin off its Elanco animal health business and posted better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Eli Lilly spins off animal health unit, second quarter beats
Eli Lilly and Co on Tuesday said it would spin off its Elanco animal health business into a publicly-traded company and posted better-than-expected quarterly profit helped by demand for its diabetes drugs Trulicity and Humalog. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Beta Bionics wins FDA nod for home-use trial of artificial pancreas tech
Beta Bionics said this week that it won FDA approval to start recruiting patients with Type I diabetes for home-use studies of its iLet bionic pancreas system. The trial is slated to test Novo Nordisk’s fast-acting insulin, Fiasp, with the company’s autonomous infusion pump in adults with Type I diabetes. The study will also evaluate insulin lispro and conventional insulin aspart combined with the iLet system in adults and kids with Type I diabetes, according to Beta Bionics. Get the full story at our sister site, Drug Delivery Business News. The post Beta Bionics wins FDA nod for home-use trial of artificial p...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Beta Bionics Eli Lilly & Co. Novo Nordisk Source Type: news

Combining AI and CGM to Make a Bionic Pancreas
A startup company is combining artificial intelligence (AI) and glucose monitoring to develop what is being called a bionic pancreas. Beta Bionics has received FDA approval to begin recruitment for the home-use studies testing an insulin-only configuration of the iLet bionic pancreas system. The U.S.-based multicenter, multi-arm, cross-over, clinical will test Novo Nordisk’s recently approved, insulin called Fiasp with the iLet bionic pancreas system in adults with type 1 diabetes, and insulin lispro and conventional insulin aspart using the iLet in adults and children with type 1 diabetes. “The device is about...
Source: MDDI - May 23, 2018 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

Admelog (Insulin Lispro Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 21, 2017 Category: Drugs & Pharmacology Source Type: news

Companion Medical launches smart insulin pen in U.S.
Companion Medical started selling its smart insulin pen in the U.S. today, according to the San Diego, Calif.-based company. The InPen system, which combines an insulin injector pen and a smartphone app, is compatible with Eli Lilly‘s (NYSE:LLY) Humalog and Novo Nordisk‘s (NYSE:NVO) Novolog fast-acting insulin. Get the full story at our sister site, Drug Delivery Business News. The post Companion Medical launches smart insulin pen in U.S. appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations mHealth (Mobile Health) Pharmaceuticals Companion Medical Eli Lilly & Co. Novo Nordisk Source Type: news

FDA Approves " Follow-On " Human Insulin Product to Treat Diabetes
Another short-acting insulin lispro injection has been approved by the FDA to treat adults and children with diabetes. The drug, marketed as Admelog, is... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 12, 2017 Category: Primary Care Source Type: news

FDA Approves New Human Insulin Product to Treat Diabetes
The short-acting insulin lispro injection has been granted final approval from the FDA to treat adults with type 2 diabetes and adults and children... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 12, 2017 Category: Primary Care Source Type: news

First Humalog Copycat (Admelog) Approved by FDA First Humalog Copycat (Admelog) Approved by FDA
Sanofi-Aventis'Admelog approved for both diabetes types, and for use via injection or insulin pump.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news

FDA approves Sanofi ’s short-acting insulin lispro injection
The FDA today approved Sanofi‘s (NYSE:SNY) Admelog insulin lispro injection. The product is indicated to help adults and kids with Type I and Type II diabetes control their blood sugar levels. Admelog is the first short-acting insulin approved using the FDA’s 505(b)(2) pathway. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves Sanofi’s short-acting insulin lispro injection appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 11, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Sanofi-Aventis Source Type: news

FDA Approves Admelog (insulin lispro) Rapid-Acting " Follow-On " Insulin Product to Treat Diabetes
December 11, 2017 -- The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a rapid-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 11, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Admelog (insulin lispro) Short-Acting " Follow-On " Insulin Product to Treat Diabetes
December 11, 2017 -- The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 11, 2017 Category: Drugs & Pharmacology Source Type: news

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog
(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog. (Source: Reuters: Health)
Source: Reuters: Health - December 11, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Says'Yes' to Short-Acting Insulin Admelog
(MedPage Today) -- Final approval for Sanofi follow-on to Humalog confirms September 2017 tentative okay (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 11, 2017 Category: American Health Source Type: news

FDA clears Sanofi's follow-on diabetes biologic of Lilly's Humalog
(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog. (Source: Reuters: Health)
Source: Reuters: Health - December 11, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves Admelog, the first short-acting " follow-on " insulin product to treat diabetes
The FDA today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus. Admelog is the first short-acting insulin approved as a “follow-on” product. (Source: Food and Drug Administration)
Source: Food and Drug Administration - December 11, 2017 Category: American Health Source Type: news

New Diabetes Drug, Admelog (Insulin Lispro), Gets FDA OK Under'Abbreviated' Pathway
MONDAY, Dec. 11, 2017 -- Admelog (insulin lispro), a short-acting form of insulin, has been approved by the U.S. Food and Drug Administration to treat people with either type of diabetes, for patients aged three years and older. It's the first drug... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 11, 2017 Category: General Medicine Source Type: news

Eli Lilly ’ s Humalog Junior KwikPen diabetes drug-device combo launches in U.S.
Eli Lilly‘s (NYSE:LLY) Humalog Junior KwikPen insulin lispro injection is available in the U.S. by prescription for people with diabetes, the company said today. The drug-device combination product is designed as a pre-filled, disposable half-unit insulin pen. Get the full story at our sister site, Drug Delivery Business News. The post Eli Lilly’s Humalog Junior KwikPen diabetes drug-device combo launches in U.S. appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - October 4, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Eli Lilly & Co. Source Type: news